SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?

BACKGROUND: Sulfotransferase 1A1 (SULT1A1) participates in the elimination of 4-hydroxy-tamoxifen (4-OH-TAM), which is one of the major active metabolites of tamoxifen (TAM). Homozygous SULT1A1 variant allele genotype has been associated with lower catalytic activity and thermostability of the enzym...

Descripción completa

Detalles Bibliográficos
Autores principales: Tengström, Maria, Mannermaa, Arto, Kosma, Veli-Matti, Hirvonen, Ari, Kataja, Vesa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388009/
https://www.ncbi.nlm.nih.gov/pubmed/22708928
http://dx.doi.org/10.1186/1471-2407-12-257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388009/
https://www.ncbi.nlm.nih.gov/pubmed/22708928
http://dx.doi.org/10.1186/1471-2407-12-257

Ejemplares similares